The Discounted Cash Flow (DCF) valuation of Globus Medical Inc (GMED) is 35.70 USD. With the latest stock price at 62.29 USD, the upside of Globus Medical Inc based on DCF is -42.7%.
Based on the latest price of 62.29 USD and our DCF valuation, Globus Medical Inc (GMED) is a sell. selling GMED stocks now will result in a potential gain of 42.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.9% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 22.14 - 94.48 | 35.70 |
| Upside | -64.5% - 51.7% | -42.7% |